Lung Cancer Surgery Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends
Top Countries — Revenue
Access the full forecast model.
Country-level data · Company profiles · Editable dataset · Analyst consultation included.
Lung Cancer Surgery Market Analysis — Presence
Geographical Analysis
Click countries to exploreRegional and Country Analysis
| Region / Country | 2021 (A) | 2025 (A) | 2033 (P) | CAGR |
|---|---|---|---|---|
| Global | xxxx | xxxx | xxxx | 6.12% |
| North America | xxxx | xxxx | xxxx | xxxx |
| United States | xxxx | xxxx | xxxx | xxxx |
| Canada | xxxx | xxxx | xxxx | xxxx |
| Mexico | xxxx | xxxx | xxxx | xxxx |
| Europe | xxxx | xxxx | xxxx | xxxx |
| United Kingdom | xxxx | xxxx | xxxx | xxxx |
| France | xxxx | xxxx | xxxx | xxxx |
| Germany | xxxx | xxxx | xxxx | xxxx |
| Italy | xxxx | xxxx | xxxx | xxxx |
| Russia | xxxx | xxxx | xxxx | xxxx |
| Spain | xxxx | xxxx | xxxx | xxxx |
| Sweden | xxxx | xxxx | xxxx | xxxx |
| Denmark | xxxx | xxxx | xxxx | xxxx |
| Switzerland | xxxx | xxxx | xxxx | xxxx |
| Luxembourg | xxxx | xxxx | xxxx | xxxx |
| Rest of Europe | xxxx | xxxx | xxxx | xxxx |
| Asia Pacific | xxxx | xxxx | xxxx | xxxx |
| China | xxxx | xxxx | xxxx | xxxx |
| Japan | xxxx | xxxx | xxxx | xxxx |
| South Korea | xxxx | xxxx | xxxx | xxxx |
| India | xxxx | xxxx | xxxx | xxxx |
| Australia | xxxx | xxxx | xxxx | xxxx |
| Singapore | xxxx | xxxx | xxxx | xxxx |
| Taiwan | xxxx | xxxx | xxxx | xxxx |
| South East Asia | xxxx | xxxx | xxxx | xxxx |
| Rest of APAC | xxxx | xxxx | xxxx | xxxx |
| South America | xxxx | xxxx | xxxx | xxxx |
| Brazil | xxxx | xxxx | xxxx | xxxx |
| Argentina | xxxx | xxxx | xxxx | xxxx |
| Colombia | xxxx | xxxx | xxxx | xxxx |
| Peru | xxxx | xxxx | xxxx | xxxx |
| Chile | xxxx | xxxx | xxxx | xxxx |
| Rest of South America | xxxx | xxxx | xxxx | xxxx |
| Middle East | xxxx | xxxx | xxxx | xxxx |
| Saudi Arabia | xxxx | xxxx | xxxx | xxxx |
| Turkey | xxxx | xxxx | xxxx | xxxx |
| UAE | xxxx | xxxx | xxxx | xxxx |
| Egypt | xxxx | xxxx | xxxx | xxxx |
| Qatar | xxxx | xxxx | xxxx | xxxx |
| Rest of Middle East | xxxx | xxxx | xxxx | xxxx |
| Africa | xxxx | xxxx | xxxx | xxxx |
| East Africa | xxxx | xxxx | xxxx | xxxx |
| West Africa | xxxx | xxxx | xxxx | xxxx |
| North Africa | xxxx | xxxx | xxxx | xxxx |
| South Africa | xxxx | xxxx | xxxx | xxxx |
A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.
Unlock full regional dataset →Segmentation Analysis
Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.
To learn more about market share and segmentation, request the free sample pages.
Competitor Analysis
Lung Cancer Surgery Industry News:
Olympus Announced the New Endobronchial Ultrasound (EBUS) Bronchoscope (May 2021)
Olympus announced the launch of the FDA 510(k)-cleared BF-UC190F endobronchial ultrasound (EBUS) bronchoscope, the newest addition to its EBUS portfolio of devices for minimally invasive lung cancer diagnosis and staging via needle biopsy.
| Top Companies (In no particular order) | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| Ethicon US | ••• | ••• | ••• | ••• |
| Intuitive Surgical | ••• | ••• | ••• | ••• |
| Olympus Corporation | ••• | ••• | ••• | ••• |
| Accuray | ••• | ••• | ••• | ••• |
| AngioDynamics | ••• | ••• | ••• | ••• |
| Teleflex | ••• | ••• | ••• | ••• |
| KARL STORZ | ••• | ••• | ••• | ••• |
| Ackermann Instrumente | ••• | ••• | ••• | ••• |
| Scanlan International | ••• | ••• | ••• | ••• |
| Trokamed | ••• | ••• | ••• | ••• |
We Provide Regional Breakdown of this Companies and Company specific to any Country, Region, Product/ service as well. We cover market share analysis for publicly listed companies as well as privately held companies, subject to data availability.
Request company profile for validation →Report Scope & Analysis
As per Cognitive Market Research's latest published report, the Global Lung Cancer Surgery market size was USD 5.82 Billion in 2022 and it is forecasted to reach USD 22.42 Billion by 2030. Lung Cancer Surgery Industry's Compound Annual Growth Rate will be 6.12% from 2023 to 2030.
Introduction of Lung Cancer Surgery
Surgery for lung cancer may involve removing all or a portion of the lung. Depending on the kind, location, and stage of their lung cancer as well as any other underlying medical issues, some people may be candidates for lung cancer surgery. Surgery is used to try to treat lung cancer. This involves removing the tumour, some lung tissue around it, and frequently some lymph nodes as well.
Analyst Conclusion
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Lung Cancer Surgery Market Analysis is witnessing significant growth in the near future.
In 2023, the Surgical Instruments segment accounted for a notable share of the Lung Cancer Surgery Market Analysis.
Frequently Asked Questions
★ Reviews
Rate this report
Lung Cancer Surgery Market Analysis — Table of Contents
- This is just a redacted sample pages of the actual deliverable report and only for representative purposes
- Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
- The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
- Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
- If applicable; On Request Volume Data will also be provided (at an Additional Cost).
| Surgical Devices | Surgical Instruments, Monitoring & Visualising systems, Endosurgical Equipment |
| End User | Hospitals, Ambulatory Surgical Centres, Others |
| Surgical Procedures | Thoracotomy, Minimally Invasive Surgeries |
| List of Competitors | Ethicon US, Intuitive Surgical, Olympus Corporation, Accuray, AngioDynamics, Teleflex, KARL STORZ, Ackermann Instrumente, Scanlan International, Trokamed |
-
1.1 Top Competitors Analysis
-
1.1.1 Global Lung Cancer Surgery Market Analysis by Key Players
(Subject to Data Availability (Private Players))
- 1.1.2 Global Lung Cancer Surgery Market Volume and Share by Key Players
- 1.1.3 Top Players Ranking 2024
- 1.1.4 New Product Launch Analysis
- 1.1.5 Industry Mergers and Acquisition Analysis
-
-
1.2 Company Profile (Data Subject to Availability) Sample Format
-
1.2.1 Ethicon US
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
- 1.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.1.2 Business Overview
- 1.2.1.3 Financials (Subject to data availability)
- 1.2.1.4 R&D Investment (Subject to data availability)
- 1.2.1.5 Product Types Specification
- 1.2.1.6 Business Strategy
- 1.2.1.7 Recent Developments
- 1.2.1.8 Management Change
- 1.2.1.9 S.W.O.T Analysis
-
1.2.2 Intuitive Surgical
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
- 1.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.2.2 Business Overview
- 1.2.2.3 Financials (Subject to data availability)
- 1.2.2.4 R&D Investment (Subject to data availability)
- 1.2.2.5 Product Types Specification
- 1.2.2.6 Business Strategy
- 1.2.2.7 Recent Developments
- 1.2.2.8 Management Change
- 1.2.2.9 S.W.O.T Analysis
-
1.2.3 Olympus Corporation
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
- 1.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.3.2 Business Overview
- 1.2.3.3 Financials (Subject to data availability)
- 1.2.3.4 R&D Investment (Subject to data availability)
- 1.2.3.5 Product Types Specification
- 1.2.3.6 Business Strategy
- 1.2.3.7 Recent Developments
- 1.2.3.8 Management Change
- 1.2.3.9 S.W.O.T Analysis
-
1.2.4 Accuray
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
- 1.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.4.2 Business Overview
- 1.2.4.3 Financials (Subject to data availability)
- 1.2.4.4 R&D Investment (Subject to data availability)
- 1.2.4.5 Product Types Specification
- 1.2.4.6 Business Strategy
- 1.2.4.7 Recent Developments
- 1.2.4.8 Management Change
- 1.2.4.9 S.W.O.T Analysis
-
1.2.5 AngioDynamics
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
- 1.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.5.2 Business Overview
- 1.2.5.3 Financials (Subject to data availability)
- 1.2.5.4 R&D Investment (Subject to data availability)
- 1.2.5.5 Product Types Specification
- 1.2.5.6 Business Strategy
- 1.2.5.7 Recent Developments
- 1.2.5.8 Management Change
- 1.2.5.9 S.W.O.T Analysis
-
1.2.6 Teleflex
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
- 1.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.6.2 Business Overview
- 1.2.6.3 Financials (Subject to data availability)
- 1.2.6.4 R&D Investment (Subject to data availability)
- 1.2.6.5 Product Types Specification
- 1.2.6.6 Business Strategy
- 1.2.6.7 Recent Developments
- 1.2.6.8 Management Change
- 1.2.6.9 S.W.O.T Analysis
-
1.2.7 KARL STORZ
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
- 1.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.7.2 Business Overview
- 1.2.7.3 Financials (Subject to data availability)
- 1.2.7.4 R&D Investment (Subject to data availability)
- 1.2.7.5 Product Types Specification
- 1.2.7.6 Business Strategy
- 1.2.7.7 Recent Developments
- 1.2.7.8 Management Change
- 1.2.7.9 S.W.O.T Analysis
-
1.2.8 Ackermann Instrumente
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
- 1.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.8.2 Business Overview
- 1.2.8.3 Financials (Subject to data availability)
- 1.2.8.4 R&D Investment (Subject to data availability)
- 1.2.8.5 Product Types Specification
- 1.2.8.6 Business Strategy
- 1.2.8.7 Recent Developments
- 1.2.8.8 Management Change
- 1.2.8.9 S.W.O.T Analysis
-
1.2.9 Scanlan International
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
- 1.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.9.2 Business Overview
- 1.2.9.3 Financials (Subject to data availability)
- 1.2.9.4 R&D Investment (Subject to data availability)
- 1.2.9.5 Product Types Specification
- 1.2.9.6 Business Strategy
- 1.2.9.7 Recent Developments
- 1.2.9.8 Management Change
- 1.2.9.9 S.W.O.T Analysis
-
1.2.10 Trokamed
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
- 1.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.10.2 Business Overview
- 1.2.10.3 Financials (Subject to data availability)
- 1.2.10.4 R&D Investment (Subject to data availability)
- 1.2.10.5 Product Types Specification
- 1.2.10.6 Business Strategy
- 1.2.10.7 Recent Developments
- 1.2.10.8 Management Change
- 1.2.10.9 S.W.O.T Analysis
-
- 2.1 Global Lung Cancer Surgery Revenue Market Size, Trend Analysis 2022 - 2034
- 2.2 Global Lung Cancer Surgery Volume Market Sales, Trend Analysis 2022 - 2034
-
2.3 Global Lung Cancer Surgery Market Analysis By Regions 2022 - 2034
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
- 2.3.1 Global Lung Cancer Surgery Revenue Market Size By Region
- 2.3.2 Global Lung Cancer Surgery Volume Market Sales By Region
-
2.4 Global Lung Cancer Surgery Market Size By Surgical Devices 2022 - 2034
- 2.4.1 Surgical Instruments Market Size
- 2.4.2 Monitoring & Visualising systems Market Size
- 2.4.3 Endosurgical Equipment Market Size
-
2.5 Global Lung Cancer Surgery Volume Market Sales By Surgical Devices 2022 - 2034
- 2.5.1 Surgical Instruments Sales Volume
- 2.5.2 Monitoring & Visualising systems Sales Volume
- 2.5.3 Endosurgical Equipment Sales Volume
-
2.6 Global Lung Cancer Surgery Market Size By End User 2022 - 2034
- 2.6.1 Hospitals Market Size
- 2.6.2 Ambulatory Surgical Centres Market Size
- 2.6.3 Others Market Size
-
2.7 Global Lung Cancer Surgery Volume Market Sales By End User 2022 - 2034
- 2.7.1 Hospitals Sales Volume
- 2.7.2 Ambulatory Surgical Centres Sales Volume
- 2.7.3 Others Sales Volume
-
2.8 Global Lung Cancer Surgery Market Size By Surgical Procedures 2022 - 2034
- 2.8.1 Thoracotomy Market Size
- 2.8.2 Minimally Invasive Surgeries Market Size
-
2.9 Global Lung Cancer Surgery Volume Market Sales By Surgical Procedures 2022 - 2034
- 2.9.1 Thoracotomy Sales Volume
- 2.9.2 Minimally Invasive Surgeries Sales Volume
- 2.10 Global Level Competitor Analysis (Subject to Data Availability (Private Players))
-
2.11 Executive Summary Global Market (2021 vs 2025 vs 2033)
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
- 2.11.1 Regional Market Revenue Summary 2021 vs 2025 vs 2033
- 2.11.2 Regional Volume Market Summary 2021 vs 2025 vs 2033
- 2.11.3 Global Market Revenue Split By Surgical Devices
- 2.11.4 Global Volume Market Split By Surgical Devices
- 2.11.5 Global Market Revenue Split By End User
- 2.11.6 Global Volume Market Split By End User
- 2.11.7 Global Market Revenue Split By Surgical Procedures
- 2.11.8 Global Volume Market Split By Surgical Procedures
-
2.11.9 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
-
3.1 North America Lung Cancer Surgery Market Outlook
- 3.1.1 North America Lung Cancer Surgery Market Size 2022 - 2034
- 3.1.2 North America Lung Cancer Surgery Volume Market Sales 2022 - 2034
- 3.1.3 North America Lung Cancer Surgery Market Size By Country 2022 - 2034
- 3.1.4 North America Lung Cancer Surgery Volume Market Sales By Country 2022 - 2034
-
3.1.5 North America Lung Cancer Surgery Market Size by Surgical Devices 2022 - 2034
- 3.1.5.1 North America Surgical Instruments Market Size
- 3.1.5.2 North America Monitoring & Visualising systems Market Size
- 3.1.5.3 North America Endosurgical Equipment Market Size
-
3.1.6 North America Lung Cancer Surgery Volume Market Sales by Surgical Devices 2022 - 2034
- 3.1.6.1 North America Surgical Instruments Sales Volume
- 3.1.6.2 North America Monitoring & Visualising systems Sales Volume
- 3.1.6.3 North America Endosurgical Equipment Sales Volume
-
3.1.7 North America Lung Cancer Surgery Market Size by End User 2022 - 2034
- 3.1.7.1 North America Hospitals Market Size
- 3.1.7.2 North America Ambulatory Surgical Centres Market Size
- 3.1.7.3 North America Others Market Size
-
3.1.8 North America Lung Cancer Surgery Volume Market Sales by End User 2022 - 2034
- 3.1.8.1 North America Hospitals Sales Volume
- 3.1.8.2 North America Ambulatory Surgical Centres Sales Volume
- 3.1.8.3 North America Others Sales Volume
-
3.1.9 North America Lung Cancer Surgery Market Size by Surgical Procedures 2022 - 2034
- 3.1.9.1 North America Thoracotomy Market Size
- 3.1.9.2 North America Minimally Invasive Surgeries Market Size
-
3.1.10 North America Lung Cancer Surgery Volume Market Sales by Surgical Procedures 2022 - 2034
- 3.1.10.1 North America Thoracotomy Sales Volume
- 3.1.10.2 North America Minimally Invasive Surgeries Sales Volume
-
4.1 Europe Lung Cancer Surgery Market Outlook
- 4.1.1 Europe Lung Cancer Surgery Market Size 2022 - 2034
- 4.1.2 Europe Lung Cancer Surgery Volume Market Sales 2022 - 2034
- 4.1.3 Europe Lung Cancer Surgery Market Size By Country 2022 - 2034
- 4.1.4 Europe Lung Cancer Surgery Volume Market Sales By Country 2022 - 2034
-
4.1.5 Europe Lung Cancer Surgery Market Size by Surgical Devices 2022 - 2034
- 4.1.5.1 Europe Surgical Instruments Market Size
- 4.1.5.2 Europe Monitoring & Visualising systems Market Size
- 4.1.5.3 Europe Endosurgical Equipment Market Size
-
4.1.6 Europe Lung Cancer Surgery Volume Market Sales by Surgical Devices 2022 - 2034
- 4.1.6.1 Europe Surgical Instruments Sales Volume
- 4.1.6.2 Europe Monitoring & Visualising systems Sales Volume
- 4.1.6.3 Europe Endosurgical Equipment Sales Volume
-
4.1.7 Europe Lung Cancer Surgery Market Size by End User 2022 - 2034
- 4.1.7.1 Europe Hospitals Market Size
- 4.1.7.2 Europe Ambulatory Surgical Centres Market Size
- 4.1.7.3 Europe Others Market Size
-
4.1.8 Europe Lung Cancer Surgery Volume Market Sales by End User 2022 - 2034
- 4.1.8.1 Europe Hospitals Sales Volume
- 4.1.8.2 Europe Ambulatory Surgical Centres Sales Volume
- 4.1.8.3 Europe Others Sales Volume
-
4.1.9 Europe Lung Cancer Surgery Market Size by Surgical Procedures 2022 - 2034
- 4.1.9.1 Europe Thoracotomy Market Size
- 4.1.9.2 Europe Minimally Invasive Surgeries Market Size
-
4.1.10 Europe Lung Cancer Surgery Volume Market Sales by Surgical Procedures 2022 - 2034
- 4.1.10.1 Europe Thoracotomy Sales Volume
- 4.1.10.2 Europe Minimally Invasive Surgeries Sales Volume
-
5.1 Asia Pacific Lung Cancer Surgery Market Outlook
- 5.1.1 Asia Pacific Lung Cancer Surgery Market Size 2022 - 2034
- 5.1.2 Asia Pacific Lung Cancer Surgery Volume Market Sales 2022 - 2034
- 5.1.3 Asia Pacific Lung Cancer Surgery Market Size By Country 2022 - 2034
- 5.1.4 Asia Pacific Lung Cancer Surgery Volume Market Sales By Country 2022 - 2034
-
5.1.5 Asia Pacific Lung Cancer Surgery Market Size by Surgical Devices 2022 - 2034
- 5.1.5.1 Asia Pacific Surgical Instruments Market Size
- 5.1.5.2 Asia Pacific Monitoring & Visualising systems Market Size
- 5.1.5.3 Asia Pacific Endosurgical Equipment Market Size
-
5.1.6 Asia Pacific Lung Cancer Surgery Volume Market Sales by Surgical Devices 2022 - 2034
- 5.1.6.1 Asia Pacific Surgical Instruments Sales Volume
- 5.1.6.2 Asia Pacific Monitoring & Visualising systems Sales Volume
- 5.1.6.3 Asia Pacific Endosurgical Equipment Sales Volume
-
5.1.7 Asia Pacific Lung Cancer Surgery Market Size by End User 2022 - 2034
- 5.1.7.1 Asia Pacific Hospitals Market Size
- 5.1.7.2 Asia Pacific Ambulatory Surgical Centres Market Size
- 5.1.7.3 Asia Pacific Others Market Size
-
5.1.8 Asia Pacific Lung Cancer Surgery Volume Market Sales by End User 2022 - 2034
- 5.1.8.1 Asia Pacific Hospitals Sales Volume
- 5.1.8.2 Asia Pacific Ambulatory Surgical Centres Sales Volume
- 5.1.8.3 Asia Pacific Others Sales Volume
-
5.1.9 Asia Pacific Lung Cancer Surgery Market Size by Surgical Procedures 2022 - 2034
- 5.1.9.1 Asia Pacific Thoracotomy Market Size
- 5.1.9.2 Asia Pacific Minimally Invasive Surgeries Market Size
-
5.1.10 Asia Pacific Lung Cancer Surgery Volume Market Sales by Surgical Procedures 2022 - 2034
- 5.1.10.1 Asia Pacific Thoracotomy Sales Volume
- 5.1.10.2 Asia Pacific Minimally Invasive Surgeries Sales Volume
-
6.1 South America Lung Cancer Surgery Market Outlook
- 6.1.1 South America Lung Cancer Surgery Market Size 2022 - 2034
- 6.1.2 South America Lung Cancer Surgery Volume Market Sales 2022 - 2034
- 6.1.3 South America Lung Cancer Surgery Market Size By Country 2022 - 2034
- 6.1.4 South America Lung Cancer Surgery Volume Market Sales By Country 2022 - 2034
-
6.1.5 South America Lung Cancer Surgery Market Size by Surgical Devices 2022 - 2034
- 6.1.5.1 South America Surgical Instruments Market Size
- 6.1.5.2 South America Monitoring & Visualising systems Market Size
- 6.1.5.3 South America Endosurgical Equipment Market Size
-
6.1.6 South America Lung Cancer Surgery Volume Market Sales by Surgical Devices 2022 - 2034
- 6.1.6.1 South America Surgical Instruments Sales Volume
- 6.1.6.2 South America Monitoring & Visualising systems Sales Volume
- 6.1.6.3 South America Endosurgical Equipment Sales Volume
-
6.1.7 South America Lung Cancer Surgery Market Size by End User 2022 - 2034
- 6.1.7.1 South America Hospitals Market Size
- 6.1.7.2 South America Ambulatory Surgical Centres Market Size
- 6.1.7.3 South America Others Market Size
-
6.1.8 South America Lung Cancer Surgery Volume Market Sales by End User 2022 - 2034
- 6.1.8.1 South America Hospitals Sales Volume
- 6.1.8.2 South America Ambulatory Surgical Centres Sales Volume
- 6.1.8.3 South America Others Sales Volume
-
6.1.9 South America Lung Cancer Surgery Market Size by Surgical Procedures 2022 - 2034
- 6.1.9.1 South America Thoracotomy Market Size
- 6.1.9.2 South America Minimally Invasive Surgeries Market Size
-
6.1.10 South America Lung Cancer Surgery Volume Market Sales by Surgical Procedures 2022 - 2034
- 6.1.10.1 South America Thoracotomy Sales Volume
- 6.1.10.2 South America Minimally Invasive Surgeries Sales Volume
-
7.1 Middle East Lung Cancer Surgery Market Outlook
- 7.1.1 Middle East Lung Cancer Surgery Market Size 2022 - 2034
- 7.1.2 Middle East Lung Cancer Surgery Volume Market Sales 2022 - 2034
- 7.1.3 Middle East Lung Cancer Surgery Market Size By Country 2022 - 2034
- 7.1.4 Middle East Lung Cancer Surgery Volume Market Sales By Country 2022 - 2034
-
7.1.5 Middle East Lung Cancer Surgery Market Size by Surgical Devices 2022 - 2034
- 7.1.5.1 Middle East Surgical Instruments Market Size
- 7.1.5.2 Middle East Monitoring & Visualising systems Market Size
- 7.1.5.3 Middle East Endosurgical Equipment Market Size
-
7.1.6 Middle East Lung Cancer Surgery Volume Market Sales by Surgical Devices 2022 - 2034
- 7.1.6.1 Middle East Surgical Instruments Sales Volume
- 7.1.6.2 Middle East Monitoring & Visualising systems Sales Volume
- 7.1.6.3 Middle East Endosurgical Equipment Sales Volume
-
7.1.7 Middle East Lung Cancer Surgery Market Size by End User 2022 - 2034
- 7.1.7.1 Middle East Hospitals Market Size
- 7.1.7.2 Middle East Ambulatory Surgical Centres Market Size
- 7.1.7.3 Middle East Others Market Size
-
7.1.8 Middle East Lung Cancer Surgery Volume Market Sales by End User 2022 - 2034
- 7.1.8.1 Middle East Hospitals Sales Volume
- 7.1.8.2 Middle East Ambulatory Surgical Centres Sales Volume
- 7.1.8.3 Middle East Others Sales Volume
-
7.1.9 Middle East Lung Cancer Surgery Market Size by Surgical Procedures 2022 - 2034
- 7.1.9.1 Middle East Thoracotomy Market Size
- 7.1.9.2 Middle East Minimally Invasive Surgeries Market Size
-
7.1.10 Middle East Lung Cancer Surgery Volume Market Sales by Surgical Procedures 2022 - 2034
- 7.1.10.1 Middle East Thoracotomy Sales Volume
- 7.1.10.2 Middle East Minimally Invasive Surgeries Sales Volume
-
8.1 Africa Lung Cancer Surgery Market Outlook
- 8.1.1 Africa Lung Cancer Surgery Market Size 2022 - 2034
- 8.1.2 Africa Lung Cancer Surgery Volume Market Sales 2022 - 2034
- 8.1.3 Africa Lung Cancer Surgery Market Size By Country 2022 - 2034
- 8.1.4 Africa Lung Cancer Surgery Volume Market Sales By Country 2022 - 2034
-
8.1.5 Africa Lung Cancer Surgery Market Size by Surgical Devices 2022 - 2034
- 8.1.5.1 Africa Surgical Instruments Market Size
- 8.1.5.2 Africa Monitoring & Visualising systems Market Size
- 8.1.5.3 Africa Endosurgical Equipment Market Size
-
8.1.6 Africa Lung Cancer Surgery Volume Market Sales by Surgical Devices 2022 - 2034
- 8.1.6.1 Africa Surgical Instruments Sales Volume
- 8.1.6.2 Africa Monitoring & Visualising systems Sales Volume
- 8.1.6.3 Africa Endosurgical Equipment Sales Volume
-
8.1.7 Africa Lung Cancer Surgery Market Size by End User 2022 - 2034
- 8.1.7.1 Africa Hospitals Market Size
- 8.1.7.2 Africa Ambulatory Surgical Centres Market Size
- 8.1.7.3 Africa Others Market Size
-
8.1.8 Africa Lung Cancer Surgery Volume Market Sales by End User 2022 - 2034
- 8.1.8.1 Africa Hospitals Sales Volume
- 8.1.8.2 Africa Ambulatory Surgical Centres Sales Volume
- 8.1.8.3 Africa Others Sales Volume
-
8.1.9 Africa Lung Cancer Surgery Market Size by Surgical Procedures 2022 - 2034
- 8.1.9.1 Africa Thoracotomy Market Size
- 8.1.9.2 Africa Minimally Invasive Surgeries Market Size
-
8.1.10 Africa Lung Cancer Surgery Volume Market Sales by Surgical Procedures 2022 - 2034
- 8.1.10.1 Africa Thoracotomy Sales Volume
- 8.1.10.2 Africa Minimally Invasive Surgeries Sales Volume
- 9.1 Market Drivers
- 9.2 Market Restraints
- 9.3 Market Trends
- 9.4 Market Opportunity
- 9.5 Technological Road Map (Subject to Data Availability)
- 9.6 Product Life Cycle (Subject to Data Availability)
-
9.7 Customer and Buyer Behavior Analysis
- 9.7.1 Consumer Demographics and Target Audience Assessment
- 9.7.2 Digital Engagement, Customer Experience & Relationship Analysis
- 9.7.3 Customer Buying Behavior & Purchase Decision Analysis
- 9.7.4 Vendor Selection, Supplier Preferences & Future Demand Trends
- 9.7.5 Pricing, Affordability & Value Perception Analysis
- 9.7.6 Customer Segmentation & Demand Pattern Analysis
- 9.8 Market Attractiveness Analysis
-
9.9 PESTEL Analysis
- 9.9.1 Political Factors
- 9.9.2 Economic Factors
- 9.9.3 Social Factors
- 9.9.4 Technological Factors
- 9.9.5 Legal Factors
- 9.9.6 Environmental Factors
-
9.10 Industrial Chain Analysis (Subject to Data Availability)
- 9.10.1 Industry Chain Analysis
- 9.10.2 Manufacturing Cost Analysis
-
9.10.3 Supply Side Analysis
- 9.10.3.1 Raw Material Analysis
- 9.10.3.2 Raw Material Procurement Analysis
- 9.10.3.3 Raw Material Price Trend Analysis
-
9.11 Porter’s Five Forces Analysis
- 9.11.1 Bargaining Power of Suppliers
- 9.11.2 Bargaining Power of Buyers
- 9.11.3 Threat of New Entrants
- 9.11.4 Threat of Substitutes
- 9.11.5 Degree of Competition
- 9.12 Patent Analysis (Subject to Data Availability)
- 9.13 ESG Analysis
-
9.14 Geopolitical Outlook
- 9.14.1 Global Power Realignment & Strategic Alliances
- 9.14.2 Geopolitical Risk Landscape & Conflict Hotspots
- 9.14.3 International Trade Relations & Market Access Environment
- 9.14.4 Regulatory & Policy Shifts Impacting Cross-Border Operations
- 9.14.5 Supply Chain Resilience, Localization & Resource Nationalism
- 9.14.6 Technology Sovereignty & Digital Geopolitics
- 9.14.7 Strategic Implications for Investment, Growth & Market Entry
-
9.15 AI & Market Transformation
This chapter isn't just about technology; it’s about certainty. We show you how AI is being used in leading industries so you can apply those same 'High-Speed' and 'High-Accuracy' principles to your own market strategy
- 9.15.1 Competitive Landscape Disruption & Strategic Shifts
- 9.15.2 AI-Driven Transformation of Industry Value Chain
- 9.15.3 Evolution of Business Models & Revenue Streams
- 9.15.4 AI-Driven Product, Service & Innovation Transformation
- 9.15.5 Customer Behavior, AI Adoption & Future Market Evolution
-
10.1 Surgical Instruments
- 10.1.1 Global Lung Cancer Surgery Revenue Market Size and Share by Surgical Instruments 2022 - 2034
- 10.1.2 Global Lung Cancer Surgery Volume Market Sales by Surgical Instruments 2022 - 2034
-
10.2 Monitoring & Visualising systems
- 10.2.1 Global Lung Cancer Surgery Revenue Market Size and Share by Monitoring & Visualising systems 2022 - 2034
- 10.2.2 Global Lung Cancer Surgery Volume Market Sales by Monitoring & Visualising systems 2022 - 2034
-
10.3 Endosurgical Equipment
- 10.3.1 Global Lung Cancer Surgery Revenue Market Size and Share by Endosurgical Equipment 2022 - 2034
- 10.3.2 Global Lung Cancer Surgery Volume Market Sales by Endosurgical Equipment 2022 - 2034
-
11.1 Hospitals
- 11.1.1 Global Lung Cancer Surgery Revenue Market Size and Share by Hospitals 2022 - 2034
- 11.1.2 Global Lung Cancer Surgery Volume Market Sales by Hospitals 2022 - 2034
-
11.2 Ambulatory Surgical Centres
- 11.2.1 Global Lung Cancer Surgery Revenue Market Size and Share by Ambulatory Surgical Centres 2022 - 2034
- 11.2.2 Global Lung Cancer Surgery Volume Market Sales by Ambulatory Surgical Centres 2022 - 2034
-
11.3 Others
- 11.3.1 Global Lung Cancer Surgery Revenue Market Size and Share by Others 2022 - 2034
- 11.3.2 Global Lung Cancer Surgery Volume Market Sales by Others 2022 - 2034
-
12.1 Thoracotomy
- 12.1.1 Global Lung Cancer Surgery Revenue Market Size and Share by Thoracotomy 2022 - 2034
- 12.1.2 Global Lung Cancer Surgery Volume Market Sales by Thoracotomy 2022 - 2034
-
12.2 Minimally Invasive Surgeries
- 12.2.1 Global Lung Cancer Surgery Revenue Market Size and Share by Minimally Invasive Surgeries 2022 - 2034
- 12.2.2 Global Lung Cancer Surgery Volume Market Sales by Minimally Invasive Surgeries 2022 - 2034
- 13.1 Global Lung Cancer Surgery Market Export Data (2022-2025)
- 13.2 Global Lung Cancer Surgery Market Import Data by Region (2022-2025)
- 13.3 Global Lung Cancer Surgery Market Export Data by Region (2022-2025)
- 13.4 North America Lung Cancer Surgery Market Import Data by Country (2019-2023)
- 13.5 North America Lung Cancer Surgery Market Export Data by Country (2019-2023)
- 13.6 Europe Lung Cancer Surgery Market Import Data by Country (2019-2023)
- 13.7 Europe Lung Cancer Surgery Market Export Data by Country (2019-2023)
- 13.8 Asia Pacific Lung Cancer Surgery Market Import Data by Country (2019-2023)
- 13.9 Asia Pacific Lung Cancer Surgery Market Export Data by Country (2019-2023)
- 13.10 South America Lung Cancer Surgery Market Import Data by Country (2019-2023)
- 13.11 South America Lung Cancer Surgery Market Export Data by Country (2019-2023)
- 13.12 Middle East and Africa Lung Cancer Surgery Market Import Data by Country (2019-2023)
- 13.13 Middle East and Africa Lung Cancer Surgery Market Export Data by Country (2019-2023)
- 15.1 Key Takeaways
-
15.2 Analyst Point of View
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
- 15.3 Assumptions and Acronyms
-
16.1 Primary Data Collection
-
16.1.1 Steps for Primary Data Collection
- 16.1.1.1 Identification of KOL
- 16.1.2 Backward Integration
- 16.1.3 Forward Integration
- 16.1.4 How Primary Research Help Us
- 16.1.5 Modes of Primary Research
-
16.1.1 Steps for Primary Data Collection
-
16.2 Secondary Research
- 16.2.1 How Secondary Research Help Us
- 16.2.2 Sources of Secondary Research
-
16.3 Data Validation
- 16.3.1 Data Triangulation
- 16.3.2 Top Down & Bottom Up Approach
- 16.3.3 Cross check KOL Responses with Secondary Data
- 16.4 Data Representation
Athenaeum AI Dashboard
Our Proprietary Methodology
Cognitive Market Research and Consulting "The Full Truth" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Lung Cancer Surgery Market Analysis Market analysis.
Primary Intelligence Gathering
Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.
Secondary Data Triangulation
Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.
Expert Validation Protocol
Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.
Athenaeum AI Processing
Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.
Editorial & QA Review
Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.
Data Assurance Metrics
Analytical Coverage
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.
Latest News about Lung Cancer Surgery Market
Sources from Pharma & Healthcare Industry
- https://en.wikipedia.org/wiki/American_Society_for_Pharmacy_Law
- https://en.wikipedia.org/wiki/American_Society_of_Consultant_Pharmacists
- https://en.wikipedia.org/wiki/American_Society_of_Health-System_Pharmacists
- https://www.apsm-uk.com/
- https://en.wikipedia.org/wiki/Australasian_College_of_Pharmacy
- https://en.wikipedia.org/wiki/American_Association_of_Colleges_of_Pharmacy
- https://en.wikipedia.org/wiki/American_College_of_Clinical_Pharmacy
- https://en.wikipedia.org/wiki/American_Pharmacists_Association
- https://www.bio.org/
- https://en.wikipedia.org/wiki/Canadian_Pharmacists_Association
- https://en.wikipedia.org/wiki/Canadian_Society_of_Hospital_Pharmacists
- https://en.wikipedia.org/wiki/Chinese_Pharmaceutical_Association
- https://en.wikipedia.org/wiki/American_Association_of_Psychiatric_Pharmacists
- https://en.wikipedia.org/wiki/Danish_Association_of_Pharmaconomists
- https://en.wikipedia.org/wiki/EPhEU
- https://www.fda.gov/
- https://www.gmc-uk.org/
- https://www.ifpma.org/
- https://www.fip.org/
- https://en.wikipedia.org/wiki/International_Pharmaceutical_Students%27_Federation
- https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
- https://en.wikipedia.org/wiki/National_Pharmacy_Association
- https://en.wikipedia.org/wiki/Norwegian_Pharmacy_Association
- https://en.wikipedia.org/wiki/Canadian_Pharmacists_Journal#History
- https://en.wikipedia.org/wiki/Pakistan_Pharmacists_Association
- https://en.wikipedia.org/wiki/Pharmaceutical_Association_of_Mauritius
- https://en.wikipedia.org/wiki/Pharmaceutical_Group_of_the_European_Union
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_Australia
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_New_Zealand
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_Northern_Ireland
- https://en.wikipedia.org/wiki/Professional_Compounding_Centers_of_America
- https://en.wikipedia.org/wiki/Royal_Pharmaceutical_Society
- https://www.aaps.org/home
- https://www.bioindustry.org/
- https://www.controlledreleasesociety.org/
- https://www.efpia.eu/
- https://www.epemed.org/online/www/content/ENG/index.html
- https://icr-global.org/
- https://ispe.org/
- https://en.wikipedia.org/wiki/Pharmaceutical_Association_of_Israel
- https://www.phrma.org/
- https://en.wikipedia.org/wiki/The_Pharmacy_Guild_of_Australia
- https://en.wikipedia.org/wiki/The_Society_of_Hospital_Pharmacists_of_Australia
- https://www.pharma-iq.com/business-development/articles/top-50-pharmaceutical-blogs-and-publications
- https://www.pharmatimes.com/news
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967517/
- https://www.cbo.gov/publication/57126
- https://www.oecd.org/els/health-systems/health-data.htm
- https://www.bls.gov/ooh/healthcare/home.htm
- https://data.worldbank.org/topic/8
- https://www.statnews.com/about/
- https://www.health.pa.gov/topics/HealthStatistics/Pages/health-statistics.aspx
- https://www.cdc.gov/nchs/index.htm
- https://www.aha.org/statistics/fast-facts-us-hospitals
- https://www.census.gov/library/publications/2021/demo/p60-274.html
- https://www.adb.org/what-we-do/sectors/health/main
The Three Pillars of End-to-End Market Research Services
We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Lung Cancer Surgery Market Analysis market.
Market Survey
Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the lung cancer surgery market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.
- Buyer intent & sentiment analysis
- Purchase cycle mapping
- Price sensitivity research
- Channel preference profiling
- Competitive perception study
Customized Market Data & Reports
Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.
- Ready syndicate report (250+ pages)
- Custom data scope & segmentation
- Excel quantitative models
- Board-ready PPT with key findings
- Secure cloud portal access
Strategic Consultation
Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.
- Dedicated analyst assigned to you
- Live walkthrough of findings
- Strategic Q&A sessions
- Go-to-market recommendations
- NDA-protected engagement
Customize This Report
Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.